{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:40:26Z","timestamp":1785368426742,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Steroid-sensitive nephrotic syndrome is an immunological disorder mediated by still poorly defined circulating factor(s) that target the podocyte and damage the filtration barrier. Fatty acids (FA) have several biological roles and, in particular, are strictly involved in cell to cell communication, inflammatory processes and regulation of lymphocyte pools. Studies of FAs during INS have been mainly focused on biochemical changes during the phase of proteinuria; while no information is available about FA profile in patients with idiopathic nephrotic syndrome (INS) on stable remission. Aim of this study is to assess differences in blood FA profile between pediatric patients with INS during the phase of stable remission. Blood fatty acid profile of 47 pediatric patients on stable remission and 47 matched healthy controls were evaluated with gas chromatography. Patients with INS on stable remission had significantly higher levels of PUFA and omega-6 than controls (40.17 vs. 37.91% and 36.95 vs. 34.79%), lower levels of SFA and MUFA. Considering the single fatty acids, levels of omega-6 18:2n6 linoleic acid and omega-6 20:4n6 arachidonic acid were significantly higher in patients with INS than in controls (23.01 vs. 21.55%, <jats:italic>p<\/jats:italic>-value 0.003 and 10.37 vs. 9.65%, <jats:italic>p<\/jats:italic>-value 0.01). Moreover, patients with INS showed lower levels of SFA 14:0 (0.74 vs. 0.92%) and 18:0 (10.74 vs. 11.74%) and MUFA 18:1n9 oleic acid (18.50 vs. 19.83%). To the best of our knowledge this is the first study assessing FAs profile in children with INS in stable remission. In a population of 47 patients, we were able to demonstrate a higher blood level of linoleic and arachidonic acid, and consequently of omega-6 and PUFA, compared to controls. Persistently higher than normal levels of either linoleic or arachidonic acid, could be viewed as candidate biomarker for a state of risk of relapse in children with idiopathic nephrotic syndrome.<\/jats:p>","DOI":"10.3389\/fped.2020.633470","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T15:30:48Z","timestamp":1611761448000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Persistent Abnormalities of Fatty Acids Profile in Children With Idiopathic Nephrotic Syndrome in Stable Remission"],"prefix":"10.3389","volume":"8","author":[{"given":"Stefano","family":"Turolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto C.","family":"Edefonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Syren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"De Cosmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tamburello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika A.","family":"Demarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berrettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianantonio","family":"Manzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fped.2016.00039","article-title":"Ethnic differences in childhood nephrotic syndrome","volume":"4","author":"Chanchlani","year":"2016","journal-title":"Front Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","article-title":"The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I\u2013diagnosis and treatment of the first episode and the first relapse","volume":"43","author":"Pasini","year":"2017","journal-title":"Ital J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00431-010-1334-0","article-title":"Clinical practice: proteinuria","volume":"170","author":"Ariceta","year":"2011","journal-title":"Eur J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D'Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fped.2019.00178","article-title":"Rituximab use in the management of childhood nephrotic syndrome","volume":"7","author":"Kallash","year":"2019","journal-title":"Front Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fped.2019.00404","article-title":"The search for biomarkers to aid in diagnosis, differentiation, and prognosis of childhood idiopathic nephrotic syndrome","volume":"7","author":"Stone","year":"2019","journal-title":"Front Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00441-019-03147-y","article-title":"Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle","volume":"379","author":"Candelier","year":"2020","journal-title":"Cell Tissue Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fped.2019.00377","article-title":"Altered B-lymphocyte homeostasis in idiopathic nephrotic syndrome","volume":"7","author":"Ling","year":"2019","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pathol.2017.01.003","article-title":"The role of interleukin-17A in the pathogenesis of kidney diseases","volume":"49","author":"Cortvrindt","year":"2017","journal-title":"Pathology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00467-016-3328-2","article-title":"Is serum CRP level a reliable inflammatory marker in pediatric nephrotic syndrome?","volume":"31","author":"Shostak","year":"2016","journal-title":"Pediatr Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jped.2017.08.005","article-title":"T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome","volume":"94","author":"Guimar\u00e3es","year":"2018","journal-title":"J Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/cei.12659","article-title":"Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome","volume":"182","author":"Jamin","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/nu10101454","article-title":"Impact of blood or erythrocyte membrane fatty acids for disease risk prediction: focusing on cardiovascular disease and chronic kidney disease","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","article-title":"Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality","volume":"139","author":"Marklund","year":"2019","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI13210","article-title":"Arachidonic acid as a bioactive molecule","volume":"107","author":"Brash","year":"2001","journal-title":"J Clin Investig"},{"key":"B19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.tibs.2018.10.007","article-title":"Eicosanoid and specialized proresolving mediator regulation of lymphoid cells","volume":"44","author":"Wei","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: a review","volume":"11","author":"Hanna","year":"2018","journal-title":"J Adv Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3390\/ijms20153683","article-title":"Arachidonic acid metabolism and kidney inflammation","volume":"20","author":"Wang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plefa.2017.08.001","article-title":"Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: new dietary sources","volume":"124","author":"Echeverr\u00eda","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1111\/j.1651-2227.2011.02343.x","article-title":"Physiological aspects of human milk lipids and implications for infant feeding: a workshop report","volume":"100","author":"Koletzko","year":"2011","journal-title":"Acta Paediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.MCHD-0035-2016","article-title":"Lipid mediators in inflammation","volume":"4","author":"Bennett","year":"2016","journal-title":"Microbiol Spectr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.jrn.2017.08.005","article-title":"Fatty acids in nephrotic syndrome and chronic kidney disease","volume":"28","author":"Turolo","year":"2018","journal-title":"J Renal Nutr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1054\/plef.2001.0311","article-title":"Effect of corticosteroids and eicosapentaenoic acid\/docosahexaenoic acid on pro-oxidant and anti-oxidant status and metabolism of essential fatty acids in patients with glomerular disorders","volume":"65","author":"Das","year":"2001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-006-0366-1","article-title":"Essential fatty acid deficiency profile in patients with nephrotic-range proteinuria","volume":"22","author":"Ald\u00e1miz-Echevarr\u00eda","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00467-003-1268-0","article-title":"Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project","volume":"19","author":"Ardissino","year":"2004","journal-title":"Pediatr Nephrol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.plefa.2006.11.004","article-title":"The fatty acid profiles in a drop of blood from a fingertip correlate with physiological, dietary and lifestyle parameters in volunteers","volume":"76","author":"Marangoni","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3390\/nu10111791","article-title":"Genome-wide association studies of estimated fatty acid desaturase activity in serum and adipose tissue in elderly individuals: associations with insulin sensitivity","volume":"10","author":"Marklund","year":"2018","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12944-019-1067-7","article-title":"The inverse association between relative abundances of oleic acid and arachidonic acid: a case of distribution dependent regulation?","volume":"18","author":"H\u00f8stmark","year":"2019","journal-title":"Lipids Health Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1476-511X-13-76","article-title":"The inverse association between relative abundances of oleic acid and arachidonic acid is related to alpha-linolenic acid","volume":"13","author":"H\u00f8stmark","year":"2014","journal-title":"Lipids Health Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cbpa.2020.04.015","article-title":"Recent advances in functional analysis of polyunsaturated fatty acid synthases","volume":"59","author":"Hayashi","year":"2020","journal-title":"Curr Opin Chem Biol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.633470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T15:30:49Z","timestamp":1611761449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.633470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":33,"alternative-id":["10.3389\/fped.2020.633470"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.633470","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"article-number":"633470"}}